Array
(
)
1
> Antifungal>Fosravuconazole L-lysine ethanolate

Antifungal

Fosravuconazole L-lysine ethanolate View larger

Fosravuconazole L-lysine ethanolate

AT8847

CAS 914361-45-8

More details

1000 Items

Molarity Calculation Cart®

HOW TO ORDER

$33.00

$33.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
15 $28.05 Total: $140.25
110 $23.76 Total: $237.60
125 $20.13 Total: $503.25
150 $17.16 Total: $858.00
1100 $14.85 Total: $1,485.00

Data sheet

Molecular FormulaC31H40F2N7O8PS
Molecular Weight739.7
CAS Numbers914361-45-8
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeN#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1.CCO.N[C@H](C(O)=O)CCCCN
ReferencesDiniz LF, Mazzeti AL, Caldas IS, Ribeiro I, Bahia MT. Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice. Antimicrob Agents Chemother. 2018;62[6] e00401-18. Published 2018 May 25. doi 10.1128AAC.00401-18Watanabe S, Tsubouchi I, Okubo A. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis A multicenter, double-blind, randomized phase III study. J Dermatol. 2018;45[10] 1151-1159. doi 10.11111346-8138.14607

More info

Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate) is a broad-spectrum antifungal agent approved in Japan for treating onychomycosis, a fungal nail infection. It is a prodrug converted into ravuconazole.